Drugs for Bone Mineral Homeostasis Flashcards
teriparatide
hrPTH; stimulates bone formation at low doses; at high doses, causes one resorption; may stimulate IGF-1
raloxifene
selective estrogen receptor modulator used for osteoporosis; has the beneficial effects of estrogen without stimulating breast cancer
denosumab
mAb to RANKL; blocks stimulation of osteocyte formation by RANKL and decreases osteoporosis
calcitonin use
short term therapy for hypercalcemia, Paget’s disease, and osteoporosis; antibody development occurs with long-term use
calcitriol MOA
stimulates Ca2+ and PO4- absorption in the small intestine; induces synthesis of calbindin; binds to transcription factor to increases mRNA and protein synthesis
calcipotriol
calcitriol analog used in the treatment of psoriasis
dihydrotachysterol
reduced vitamin D2, less effective than calcitriol; used in the treatment of osteoporosis
paricalcitol
calcitriol analog; reduces PTH secretion
22-oxacalcitriol
suppresses PTH gene expression
bisphosphonates moa
reduce resorption and formation of bone by acting on the basic hydroxyappetite crystal structure
bisphosphonates used for paget’s disease
etidronate (1st gen), alendronate (2nd gen) and risedronate (3rd gen)
bisphosphonates used for osteoporosis
alendronate
bisphosphonates pharmacology
all are absorbed poorly; must be taken after an overnight fast with a full glass of water and no food for 30 minutes
bisphosphonates adverse effects
osteonecrosis of the jaw; renal impairment
glucocorticoids
antagonize Ca uptake in the intestine; common cause of osteoporosis; useful in reversing lymphoma-induced hypercalcemia